EisnerAmper Podcast

Engaging Alternatives Spotlight: AI and Technology Venture Growth Investing

In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, speaks with Al Tarar, CEO, Founder and Managing Partner of Quartus Capital Partners LLC, which specializes in scaling growth-stage AI and technology ventures. He shares his outlook for investing in those ventures, including the greatest opportunities and challenges. He also shares how the firm integrates ESG/DEI and more.

Engaging Alternatives Spotlight: Venture Capital Investing in Biotech and Therapeutics

In this episode of Engaging Alternatives Spotlight,  Elana Margulies-Snyderman, Director, Publications, speaks with Christina Ansted and Michael Janes, Senior Managing Partners at RCP Ventures, a Cambridge, Massachusetts-based venture capital firm that invests in biotech and therapeutics. They share the outlook for VC investing in those industries, including the greatest opportunities and challenges. They also discuss how the firm integrates ESG, DEI and more.

TechTalk: Grant-Funded Startup Revolutionizes Breast Cancer Care with Digital Health

Jennifer Johnson, Founder and CEO of JennJ Health and Fitness, talks with EisnerAmper's TechTalk host Janina Teoxon about her remarkable journey from being a cancer patient to launching a startup that’s focused on closing the health equity gap for all patients. In this episode, discover how Jennifer is leveraging an innovative AI-driven fitness solution for breast cancer patients, empowering them with data that can positively influence their medical treatment. Tune in to gain valuable insights from Jennifer on applying for grant funding, and learn what success truly means to her.

Engaging Alternatives Spotlight: Venture Capital Investing in Health Care

In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Todd Perman, President & CEO, SEED Healthcare, a venture capital firm that invests in health care. Todd shares his outlook for VC investing in the space including the greatest opportunities and challenges. He also shares how he integrates ESG.

Engaging Alternatives Spotlight: Venture Capital Investing in Female-Founded Wellness Brands

In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, speaks with Rachel Hirsch, Managing Partner, Wellness Growth Ventures, a Los Angeles-based venture capital fund that invests in female-founded wellness brands. Rachel will share her outlook for VC investing in female-founded wellness brands, including the greatest opportunities and challenges. She also discusses how the firm integrates ESG, her experience being a woman in the industry and more.

Engaging Alternatives Spotlight: Specialty Real Estate Finance in New England

In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, speaks with Chris Johnson, Partner at Tailor Ridge Capital Management, a real estate credit manager focused on making bridge and construction loans secured by smaller residential assets. Chris shares the outlook for this asset class generally and in the New England region in particular, including the greatest opportunities and challenges and more.

Private Equity Dealbook: Private Equity Dealmaking for Primaries, Secondaries and Co-Investments

In this episode of EisnerAmper's Private Equity Dealbook, Elana Margulies-Snyderman, Director, Publications, speaks with Andrew Bernstein, Senior Managing Director and Head of Private Equity at Capital Dynamics, a $14 billion independent global asset management firm focused on private assets.  Andrew shares his outlook for dealmaking in private equity including opportunities, challenges, how the climate has impacted transactions, the due diligence process for M&A activity and more.

TechTalk: Biotech Startup Evolving the Journey to Therapeutic Antibody Discovery

Andrew Satz, Co-Founder and CEO of EVQLV, talks with EisnerAmper's TechTalk host Fritz Spencer about his startup’s mission to leverage advances in computation to revolutionize the discovery and engineering of therapeutic antibodies. In this episode, Andrew discusses how his proprietary platform generates “intellectual property as a service” for fully human antibodies, significantly reducing development costs and time. Tune in to hear how EVQLV aims to accelerate the creation of personalized medicines, paving the way for a future where treatments are tailored to each individual patient.

Construction Surety Trends & Market Outlook: Episode 4

In the last episode of this four-part podcast series, Don Hoffman, EisnerAmper Partner and National Construction Leader, speaks with Brian Whipple, National Surety Practice Leader at Risk Strategies, about trends in surety, the surety market outlook, and offer advice on what you can do if you’re involved in a construction claim or dispute.

Engaging Alternatives Spotlight: GP Stakes Private Equity Fund Investing

In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, speaks with Lincoln Archibald, Co-Founder and Chief Investment Officer of Fund Launch Partners, a Utah-based growth equity private equity firm that specializes in acquiring GP stakes in emerging funds.  Lincoln share his outlook for acquiring GP stakes in emerging funds, including the greatest opportunities and challenges, how the firm approaches ESG, DEI and more.